Financhill
Back

Seres Therapeutics Stock Predictions

Seres Therapeutics Stock Forecast

  • Is Seres Therapeutics Stock Undervalued?
    The current Seres Therapeutics [MCRB] share price is $0.59. The Score for MCRB is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • MCRB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Seres Therapeutics Stock Go Up Next Year?

Data Unavailable

Seres Therapeutics Stock Rating

Data Unavailable

Seres Therapeutics Stock Price History

Is MCRB stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MCRB is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
serestherapeutics.com

52-Week Data

52-Week High:
2.05
52-Week Low:
0.54

Prediction Charts

Market Cap:
89.55M
Price in USD:
0.59
Volume:
5.38M
Beta:
2.03

Technical Analysis

SMA50:
0.86
SMA100:
0.93
SMA200:
0.92
52-Wk Change:
-44.84%

Stock Predictions

  • Is Seres Therapeutics stock public?
    Yes, Seres Therapeutics is a publicly traded company.
  • What is the Seres Therapeutics stock quote today?
    The Seres Therapeutics stock price is 0.59 USD today.
  • How to buy Seres Therapeutics stock online?
    You can buy Seres Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-25 0.72 0.70 0.75 0.68
Oct-28 0.69 0.70 0.76 0.69
Oct-29 0.71 0.78 0.79 0.71
Oct-30 0.76 0.81 0.81 0.75
Oct-31 0.78 0.80 0.83 0.76
Nov-1 0.79 0.82 0.83 0.79
Nov-4 0.83 0.80 0.85 0.79
Nov-5 0.79 0.81 0.82 0.76
Nov-6 0.84 0.76 0.84 0.74
Nov-7 0.75 0.72 0.76 0.71
Nov-8 0.70 0.72 0.73 0.70
Nov-11 0.74 0.69 0.76 0.69
Nov-12 0.69 0.66 0.71 0.63
Nov-13 0.65 0.59 0.69 0.59

Seres Therapeutics Earnings

Data Unavailable

Seres Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.31 per share, and an increase next year of $0.18 per share.

* Seres Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.